243 related articles for article (PubMed ID: 24270891)
1. Deubiquitylation and stabilization of PTEN by USP13.
Zhang J; Zhang P; Wei Y; Piao HL; Wang W; Maddika S; Wang M; Chen D; Sun Y; Hung MC; Chen J; Ma L
Nat Cell Biol; 2013 Dec; 15(12):1486-1494. PubMed ID: 24270891
[TBL] [Abstract][Full Text] [Related]
2. BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN.
Deng R; Guo Y; Li L; He J; Qiang Z; Zhang H; Chen R; Wang Y; Zhao X; Yu J
Mol Oncol; 2021 Jan; 15(1):279-298. PubMed ID: 33155366
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitylation and regulation of the immune response.
Sun SC
Nat Rev Immunol; 2008 Jul; 8(7):501-11. PubMed ID: 18535581
[TBL] [Abstract][Full Text] [Related]
4. USP13 regulates cell senescence through mediating MDM2 stability.
He J; Baoyinna B; Taleb SJ; Zhao J; Zhao Y
Life Sci; 2023 Oct; 331():122044. PubMed ID: 37634814
[TBL] [Abstract][Full Text] [Related]
5. Roles of ubiquitin‑specific protease 13 in normal physiology and tumors (Review).
Tao Y; Xu X; Shen R; Miao X; He S
Oncol Lett; 2024 Feb; 27(2):58. PubMed ID: 38192665
[TBL] [Abstract][Full Text] [Related]
6. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.
Zhang P; Wei Y; Wang L; Debeb BG; Yuan Y; Zhang J; Yuan J; Wang M; Chen D; Sun Y; Woodward WA; Liu Y; Dean DC; Liang H; Hu Y; Ang KK; Hung MC; Chen J; Ma L
Nat Cell Biol; 2014 Sep; 16(9):864-75. PubMed ID: 25086746
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis.
Yuan L; Lv Y; Li H; Gao H; Song S; Zhang Y; Xing G; Kong X; Wang L; Li Y; Zhou T; Gao D; Xiao ZX; Yin Y; Wei W; He F; Zhang L
Nat Cell Biol; 2015 Sep; 17(9):1169-81. PubMed ID: 26280536
[TBL] [Abstract][Full Text] [Related]
8. USP13 antagonizes gp78 to maintain functionality of a chaperone in ER-associated degradation.
Liu Y; Soetandyo N; Lee JG; Liu L; Xu Y; Clemons WM; Ye Y
Elife; 2014; 3():e01369. PubMed ID: 24424410
[TBL] [Abstract][Full Text] [Related]
9. miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.
Zhang P; Wang L; Rodriguez-Aguayo C; Yuan Y; Debeb BG; Chen D; Sun Y; You MJ; Liu Y; Dean DC; Woodward WA; Liang H; Yang X; Lopez-Berestein G; Sood AK; Hu Y; Ang KK; Chen J; Ma L
Nat Commun; 2014 Dec; 5():5671. PubMed ID: 25476932
[TBL] [Abstract][Full Text] [Related]
10. α-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-κB signalling.
Piao HL; Yuan Y; Wang M; Sun Y; Liang H; Ma L
Nat Cell Biol; 2014 Mar; 16(3):245-54. PubMed ID: 24509793
[TBL] [Abstract][Full Text] [Related]
11. AMPK modulates Hippo pathway activity to regulate energy homeostasis.
Wang W; Xiao ZD; Li X; Aziz KE; Gan B; Johnson RL; Chen J
Nat Cell Biol; 2015 Apr; 17(4):490-9. PubMed ID: 25751139
[TBL] [Abstract][Full Text] [Related]
12. Amplification of USP13 drives ovarian cancer metabolism.
Han C; Yang L; Choi HH; Baddour J; Achreja A; Liu Y; Li Y; Li J; Wan G; Huang C; Ji G; Zhang X; Nagrath D; Lu X
Nat Commun; 2016 Nov; 7():13525. PubMed ID: 27892457
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitination and Activation of AMPK by USP10.
Deng M; Yang X; Qin B; Liu T; Zhang H; Guo W; Lee SB; Kim JJ; Yuan J; Pei H; Wang L; Lou Z
Mol Cell; 2016 Feb; 61(4):614-624. PubMed ID: 26876938
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination.
Fang X; Zhou W; Wu Q; Huang Z; Shi Y; Yang K; Chen C; Xie Q; Mack SC; Wang X; Carcaboso AM; Sloan AE; Ouyang G; McLendon RE; Bian XW; Rich JN; Bao S
J Exp Med; 2017 Jan; 214(1):245-267. PubMed ID: 27923907
[TBL] [Abstract][Full Text] [Related]
15. USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response.
Li Y; Luo K; Yin Y; Wu C; Deng M; Li L; Chen Y; Nowsheen S; Lou Z; Yuan J
Nat Commun; 2017 Jun; 8():15752. PubMed ID: 28569838
[TBL] [Abstract][Full Text] [Related]
16. USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer.
Pan J; Deng Q; Jiang C; Wang X; Niu T; Li H; Chen T; Jin J; Pan W; Cai X; Yang X; Lu M; Xiao J; Wang P
Oncogene; 2015 Jul; 34(30):3957-67. PubMed ID: 25284584
[TBL] [Abstract][Full Text] [Related]
17. miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion.
Chen D; Sun Y; Yuan Y; Han Z; Zhang P; Zhang J; You MJ; Teruya-Feldstein J; Wang M; Gupta S; Hung MC; Liang H; Ma L
PLoS Genet; 2014 Feb; 10(2):e1004177. PubMed ID: 24586203
[TBL] [Abstract][Full Text] [Related]
18. Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth.
Li N; Zhang Y; Han X; Liang K; Wang J; Feng L; Wang W; Songyang Z; Lin C; Yang L; Yu Y; Chen J
Genes Dev; 2015 Jan; 29(2):157-70. PubMed ID: 25547115
[TBL] [Abstract][Full Text] [Related]
19. Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer.
Pal A; Young MA; Donato NJ
Cancer Res; 2014 Sep; 74(18):4955-66. PubMed ID: 25172841
[TBL] [Abstract][Full Text] [Related]
20. Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors.
Zhang S; Zhang M; Jing Y; Yin X; Ma P; Zhang Z; Wang X; Di W; Zhuang G
Nat Commun; 2018 Jan; 9(1):215. PubMed ID: 29335437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
